538 related articles for article (PubMed ID: 30521673)
1. Inhaled steroids with and without regular salmeterol for asthma: serious adverse events.
Cates CJ; Schmidt S; Ferrer M; Sayer B; Waterson S
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD006922. PubMed ID: 30521673
[TBL] [Abstract][Full Text] [Related]
2. Inhaled steroids with and without regular formoterol for asthma: serious adverse events.
Janjua S; Schmidt S; Ferrer M; Cates CJ
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD006924. PubMed ID: 31553802
[TBL] [Abstract][Full Text] [Related]
3. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events.
Cates CJ; Jaeschke R; Schmidt S; Ferrer M
Cochrane Database Syst Rev; 2013 Mar; (3):CD006922. PubMed ID: 23543548
[TBL] [Abstract][Full Text] [Related]
4. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events.
Cates CJ; Lasserson TJ; Jaeschke R
Cochrane Database Syst Rev; 2009 Jul; (3):CD006922. PubMed ID: 19588410
[TBL] [Abstract][Full Text] [Related]
5. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.
O'Shea O; Stovold E; Cates CJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD007694. PubMed ID: 33852162
[TBL] [Abstract][Full Text] [Related]
6. Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events.
Cates CJ; Jaeschke R; Schmidt S; Ferrer M
Cochrane Database Syst Rev; 2013 Jun; (6):CD006924. PubMed ID: 23744625
[TBL] [Abstract][Full Text] [Related]
7. Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews.
Cates CJ; Wieland LS; Oleszczuk M; Kew KM
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD010314. PubMed ID: 24504983
[TBL] [Abstract][Full Text] [Related]
8. Regular treatment with salmeterol for chronic asthma: serious adverse events.
Cates CJ; Cates MJ
Cochrane Database Syst Rev; 2008 Jul; (3):CD006363. PubMed ID: 18646149
[TBL] [Abstract][Full Text] [Related]
9. Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews.
Cates CJ; Oleszczuk M; Stovold E; Wieland LS
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD010005. PubMed ID: 23076961
[TBL] [Abstract][Full Text] [Related]
10. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.
Cates CJ; Lasserson TJ
Cochrane Database Syst Rev; 2010 Jan; (1):CD007694. PubMed ID: 20091646
[TBL] [Abstract][Full Text] [Related]
11. Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events.
Cates CJ; Lasserson TJ
Cochrane Database Syst Rev; 2012 Mar; 3(3):CD007695. PubMed ID: 22419326
[TBL] [Abstract][Full Text] [Related]
12. Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events.
Cates CJ; Lasserson TJ; Jaeschke R
Cochrane Database Syst Rev; 2009 Apr; (2):CD006924. PubMed ID: 19370661
[TBL] [Abstract][Full Text] [Related]
13. Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma.
Crossingham I; Turner S; Ramakrishnan S; Fries A; Gowell M; Yasmin F; Richardson R; Webb P; O'Boyle E; Hinks TS
Cochrane Database Syst Rev; 2021 May; 5(5):CD013518. PubMed ID: 33945639
[TBL] [Abstract][Full Text] [Related]
14. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.
Cates CJ; Lasserson TJ
Sao Paulo Med J; 2010; 128(5):310-1. PubMed ID: 21181075
[TBL] [Abstract][Full Text] [Related]
15. Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events.
Cates CJ; Lasserson TJ
Cochrane Database Syst Rev; 2009 Oct; (4):CD007695. PubMed ID: 19821436
[TBL] [Abstract][Full Text] [Related]
16. Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children.
Chauhan BF; Chartrand C; Ni Chroinin M; Milan SJ; Ducharme FM
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD007949. PubMed ID: 26594816
[TBL] [Abstract][Full Text] [Related]
17. Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children.
Cates CJ; Karner C
Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD007313. PubMed ID: 23633340
[TBL] [Abstract][Full Text] [Related]
18. Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
Nannini LJ; Lasserson TJ; Poole P
Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD006829. PubMed ID: 22972099
[TBL] [Abstract][Full Text] [Related]
19. Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children.
Ducharme FM; Ni Chroinin M; Greenstone I; Lasserson TJ
Cochrane Database Syst Rev; 2010 May; (5):CD005535. PubMed ID: 20464739
[TBL] [Abstract][Full Text] [Related]
20. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma.
Anderson DE; Kew KM; Boyter AC
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011397. PubMed ID: 26301488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
